Publicaciones en las que colabora con TOMAS M. M. GARCIA-CABALLERO PARADA (18)

2024

  1. Edoxaban treatment in a post-infarction experimental model

    European Journal of Pharmacology, Vol. 962

2022

  1. The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure

    Cells, Vol. 11, Núm. 8

2018

  1. An immunohistochemical score to predict the outcome for oral squamous cell carcinoma

    Journal of Oral Pathology and Medicine, Vol. 47, Núm. 4, pp. 375-381

  2. Effects of dapagliflozin on human epicardial adipose tissue: Modulation of insulin resistance, inflammatory chemokine production, and differentiation ability

    Cardiovascular Research, Vol. 114, Núm. 2, pp. 336-346

  3. Prognostic significance of cyclins A2, B1, D1, and E1 and CCND1 numerical aberrations in oral squamous cell carcinomas

    Analytical Cellular Pathology, Vol. 2018

2015

  1. IL-36α: A novel cytokine involved in the catabolic and inflammatory response in chondrocytes

    Scientific Reports, Vol. 5

2014

  1. Immunohistochemical evaluation of EGFR expression in lip squamous cell carcinoma. Correlation with clinicopathological characteristics

    Histology and Histopathology, Vol. 29, Núm. 5, pp. 641-648

2012

  1. Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma

    Journal of Oral Pathology and Medicine, Vol. 41, Núm. 7, pp. 559-567

  2. Er,CR:YSGG lasers induce fewer dysplastic-like epithelial artefacts than CO2 lasers: An in vivo experimental study on oral mucosa

    British Journal of Oral and Maxillofacial Surgery, Vol. 50, Núm. 6, pp. 508-512

2010

  1. EGFR and Ki-67 expression in oral squamous cell carcinoma using tissue microarray technology.

    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, Vol. 39, Núm. 7, pp. 571-578

  2. Gingival mucinous adenocarcinoma of a minor salivary gland

    Journal of Periodontology, Vol. 81, Núm. 4, pp. 626-631

2007

  1. Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma

    Oral Diseases, Vol. 13, Núm. 3, pp. 285-290

2006

  1. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma

    Oral Oncology, Vol. 42, Núm. 2, pp. 190-200

2000

  1. Expression of growth hormone receptor in benign and malignant cutaneous proliferative entities

    Journal of Cutaneous Pathology, Vol. 27, Núm. 6, pp. 276-282

  2. Hormona del crecimiento y dermatología

    Actas Dermo-Sifiliograficas, Vol. 91, Núm. 7-8, pp. 305-317

  3. Relations entre la survie et l'index de proliferation cellulaire dans les cancers epidermoides du larynx

    Revue de Laryngologie Otologie Rhinologie, Vol. 121, Núm. 2, pp. 121-125

1997

  1. Cellular and subcellular distribution of 7B2 in porcine merkel cells

    Anatomical Record, Vol. 248, Núm. 2, pp. 159-163

1987

  1. Morphometric characterization of the human neuroendocrine merkel cells

    Journal of Investigative Dermatology, Vol. 88, Núm. 6, pp. 766-768